Page last updated: 2024-08-24

triciribine and sirolimus

triciribine has been researched along with sirolimus in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A1
Esteva, FJ; Hortobagyi, GN; Lan, KH; Lu, CH; Mills, GB; Neal, CL; Sun, MH; Tseng, LM; Wyszomierski, SL; Yu, D1
Chen, W; Cheng, J; Ji, X; Kong, J; Li, J; Mujahid, H; Wang, H; Yin, Y; Zhai, C; Zhang, Y1
Kang, C; Li, L; Li, Z; Pan, X; Wang, Y; Zhou, Q1

Other Studies

4 other study(ies) available for triciribine and sirolimus

ArticleYear
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
    The Biochemical journal, 2013, Apr-15, Volume: 451, Issue:2

    Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase

2013
Preclinical testing of clinically applicable strategies for overcoming trastuzumab resistance caused by PTEN deficiency.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Oct-01, Volume: 13, Issue:19

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Everolimus; Female; Humans; Mice; Mice, SCID; Neoplasm Transplantation; Neoplasms; PTEN Phosphohydrolase; Ribonucleosides; Sirolimus; Trastuzumab

2007
Selective inhibition of PI3K/Akt/mTOR signaling pathway regulates autophagy of macrophage and vulnerability of atherosclerotic plaque.
    PloS one, 2014, Volume: 9, Issue:3

    Topics: Animals; Atherosclerosis; Autophagy; Cells, Cultured; Chromones; Cytokines; Lipids; Macrophages, Peritoneal; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Plaque, Atherosclerotic; Proto-Oncogene Proteins c-akt; Rabbits; Ribonucleosides; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases

2014
Assessment of tantalum nanoparticle-induced MC3T3-E1 proliferation and underlying mechanisms.
    Journal of materials science. Materials in medicine, 2021, Oct-23, Volume: 32, Issue:11

    Topics: 3T3 Cells; Animals; Apoptosis; Biocompatible Materials; Cell Proliferation; Chromones; Gene Expression Regulation; Materials Testing; Metal Nanoparticles; Mice; Microtubule-Associated Proteins; Morpholines; Ribonucleosides; Sirolimus; Tantalum

2021